Growth Metrics

Sotera Health (SHC) Cash & Equivalents (2020 - 2025)

Sotera Health has reported Cash & Equivalents over the past 6 years, most recently at $344.6 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $344.6 million for Q4 2025, up 24.3% from a year ago — trailing twelve months through Dec 2025 was $344.6 million (up 24.3% YoY), and the annual figure for FY2025 was $344.6 million, up 24.3%.
  • Cash & Equivalents for Q4 2025 was $344.6 million at Sotera Health, up from $299.2 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SHC hit a ceiling of $647.9 million in Q1 2023 and a floor of $106.9 million in Q4 2021.
  • Median Cash & Equivalents over the past 5 years was $261.9 million (2023), compared with a mean of $256.5 million.
  • Biggest five-year swings in Cash & Equivalents: surged 433.55% in 2023 and later plummeted 59.7% in 2024.
  • Sotera Health's Cash & Equivalents stood at $106.9 million in 2021, then soared by 269.65% to $395.2 million in 2022, then dropped by 25.0% to $296.4 million in 2023, then decreased by 6.47% to $277.2 million in 2024, then grew by 24.3% to $344.6 million in 2025.
  • The last three reported values for Cash & Equivalents were $344.6 million (Q4 2025), $299.2 million (Q3 2025), and $332.4 million (Q2 2025) per Business Quant data.